The FTC and HHS say they are attempting to uncover the causes of generic drug shortages and identify potential solutions to end these shortages. The FTC and HHS say they are attempting to uncover the causes of generic drug shortages and identify potential solutions to end these shortages.
For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and officials are pushing drugmakers to study lower doses early in the research process.
Cancer Patients, Doctors Push Back Against Drugs' Harsh Side Effects bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary.
Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable. Harsh side effects from powerful cancer drugs have long been accepted as a trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. The U.S. Food and Drug Administration is pushing drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. One group is planning a study to test whether lower doses of two new drugs will work for breast cancer that has spread.